Clinical Trial Update: Safety and Virologic Effect of a Human Monoclonal Antibody (VRC01) Administered Intravenously to Adults During Early Acute HIV Infection [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and virologic effects of the human monoclonal antibody VRC01 given intravenously to adults during early acute HIV infectio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VRC01 (VRC01)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2025-12-17